Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |